Related stories
Shanghai Pharmaceuticals Controlling Shareholder Plans H-Share Purchase
Shanghai Pharmaceuticals said its controlling shareholder plans to increase its holdings of the company’s H shares.
M impact | EQUITY | Nov 04, 2026, 08:39 AM UTC
HUDCO Reports Q2 Consolidated Operating Revenue of INR 40,404.2 Million
M impact | EQUITY | Nov 04, 2026, 08:39 AM UTC
HUDCO Reports Q2 Consolidated Net Profit of INR 9,110.4 Million
M impact | EQUITY | Nov 04, 2026, 08:39 AM UTC
Memray BT Repurchases KRW 500 Million in Debt Ahead of Maturity
L impact | EQUITY | Nov 04, 2026, 08:38 AM UTC
Farcent Enterprise Reports Third-Quarter Net Profit of NT$83.6M
The Taiwan company reported third-quarter net profit of NT$83.6 million, compared with NT$80.9 million a year earlier. Revenue was NT$623.868 million versus NT$581.331 million.
M impact | EQUITY | Nov 04, 2026, 08:38 AM UTC
Sinkang Industries Reports Third-Quarter Net Profit of NT$29.1 Million
The company reported third-quarter net profit of NT$29.1 million, compared with NT$32.4 million a year earlier. Revenue was NT$829,417,000 versus NT$819,058,000; pretax profit was
M impact | EQUITY | Nov 04, 2026, 08:37 AM UTC